|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
IRCT |
|
Last refreshed on:
|
22 February 2018 |
|
Main ID: |
IRCT2014012511700N3 |
|
Date of registration:
|
2014-02-05 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Effect of combined dexamethasone-ondansetrone versus dexamethasone and ondansetrone alone for the prevention of nausea and vomiting after outpatient gynecological diagnostic laparoscopy
|
|
Scientific title:
|
Effect of dexamethasone-ondansetrone for the prevention of nausea and vomiting after laparoscopy |
|
Date of first enrolment:
|
2013-03-20 |
|
Target sample size:
|
105 |
|
Recruitment status: |
Complete |
|
URL:
|
http://en.irct.ir/trial/11878 |
|
Study type:
|
interventional |
|
Study design:
|
Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Prevention.
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
Iran (Islamic Republic of)
| | | | | | | |
|
Contacts
|
|
Name:
|
Dr. Farnaz Moslemi
|
|
Address:
|
Alzahra Hospital, Artesh Ave, Tabriz
Tabriz
Iran (Islamic Republic of) |
|
Telephone:
|
+98 41 1553 9161 |
|
Email:
|
moslemi_fa@yahoo.com |
|
Affiliation:
|
Tabriz University of Medical Sciences |
|
|
Name:
|
Dr. Farnaz Moslemi
|
|
Address:
|
Alzahra Hospital, Artesh Ave, Tabriz
Tabriz
Iran (Islamic Republic of) |
|
Telephone:
|
+98 41 1553 9161 |
|
Email:
|
moslemi_fa@yahoo.com |
|
Affiliation:
|
Tabriz university of Medical Sciences |
| |
|
Key inclusion & exclusion criteria
|
Inclusion criteria: Inclusion criteria: women with 20-50 years old; women with ASA physical status I and II; patients who have given informed concent
Exclusio criteria: patients with ASA physical status III or higher;cardiovascular disease; respiratory disease; gastrointestinal disease; hypertension; diabet; patients who had antiemetic therapy
Exclusion criteria:
Age minimum:
20 years
Age maximum:
50 years
Gender:
Female
|
|
Health Condition(s) or Problem(s) studied
|
|
Other complications of spinal and epidural anaesthesia during labour and delivery
|
Nausea and Vomiting.
Other complications of spinal and epidural anaesthesia during labour and delivery
|
|
Intervention(s)
|
|
Intervention 1: Group 1, will recieve 8 mg IV Dexamethazone before induction of anesthesia. Intervention 2: Group2 will recieve 4 mg IV ondansetron before induction of anesthesia. Intervention 3: Group 3 will recieve 8 mg Dexamethazone and 4 mg Ondansetron IV before induction of anesthesia.
|
|
Treatment - Drugs
|
|
Group 3 will recieve 8 mg Dexamethazone and 4 mg Ondansetron IV before induction of anesthesia
|
|
Group 1, will recieve 8 mg IV Dexamethazone before induction of anesthesia
|
|
Group2 will recieve 4 mg IV ondansetron before induction of anesthesia
|
|
Primary Outcome(s)
|
|
Nausea and Vomiting. Timepoint: In recovery room and until discharge of Hospital. Method of measurement: The intencity of nausea and vomiting with Belville score.
|
|
Source(s) of Monetary Support
|
|
Tabriz University of Medical Sciences
|
|
Ethics review
|
Status: Approved
Approval date:
Contact:
Vice Chancellor for Reaserch, Tabriz University of Medical Sciences
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|